<DOC>
	<DOCNO>NCT01332006</DOCNO>
	<brief_summary>For great majority hematological malignancy , hemopoietic stem cell ( HSC ) transplant possible cure . The source HSC usually bone marrow ( BM ) peripheral blood cell ( PBSC ) mobilize granulocyte growth factor . Transplant need HLA compatible donor weather relate unrelated . A suitable compatible donor find least 70 % patient . Thus , least 30 % patient indication allogeneic HSC transplant able undergo procedure lack HLA compatible donor . Cord blood ( CB ) cell represent another possible source , need low degree HLA compatibility . CB transplant , however , offer low number HSC . Thus , adult patient rarely may benefit source stem cell , mainly beacuse thie body weight high ad adequate number cell per kg . Recently , experimental animal model confirm adequate recovery allogeneic hemopoiesis achieve via intrabone injection , use 1Log low number cell compare intravenous way ( Yahata 2003 , Castello 2004 ) . Safety feasibility intrabone infusion verify two clinical study human : first conduct Ringden O. et al . 18 patient use BM source SC . No side effect complete engraftment donor hemopoiesis observe ; second one conduct Frassoni et al . ( Frassoni 2008 ) CB source HSC . The aim study evaluate intrabone infusion compatible CB patient haematological malignancy lack HLA match donor . We perform : evaluation engraftment kinetics ; evaluation chimerism degree 30 , 60 , 100 day , 6 month 1 year transplant ; study immunological reconstitution role NK compartment .</brief_summary>
	<brief_title>Intra-bone Cord Blood Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<criteria>Age 18 65 year . Patients affect hematological malignancy without HLA identical sibling donor unrelated donor . Informed consent . Patients ECOG &lt; 2 . Patients blood creatine &gt; 2 mg/dl transaminase cholestase index &gt; 5 time compare normality upper limit . Patients Cardiac Fraction Ejection &lt; 40 % . Patients DLCO &lt; 60 % Diffusing Lung Capacity carbon monoxide attest severe pulmonary insufficiency . Patients peripheral blast cell count 10 % . Second neoplasia diagnose 2 year . Patients active suspected infection fungi therapeutic treatment ongoing . HIV positive patient . HCVRNA HBVDNA positive patient Pregnant lactating woman . Severe mental disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>